# QUICKLOGIC Corp: financial statements, quarterly

QUIK · Nasdaq · CIK 882508 · [Technology](/sectors/technology.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/quik.md) · [Financials](/companies/quik/financials.md) · [Filings](/companies/quik/filings.md) · [Insiders](/companies/quik/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/quik/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [6,665](/filings/0001437749-24-034931.md) | [7,479 d](/filings/0001437749-25-009211.md) | [5,669](/filings/0001437749-25-016834.md) | [4,096](/filings/0001437749-25-026521.md) | [4,209](/filings/0001437749-25-034456.md) | [5,677 d](/filings/0001437749-26-010089.md) | [4,325](/filings/0001437749-26-016727.md) | [3,687](/filings/0001437749-26-027326.md) | [2,029](/filings/0001437749-25-034456.md) | [3,733 d](/filings/0001437749-26-010089.md) | [5,051](/filings/0001437749-26-016727.md) | [5,482](/filings/0001437749-26-027326.md) |
| Cost of revenue | $k | [1,537](/filings/0001437749-24-034931.md) | [1,713 d](/filings/0001437749-25-009211.md) | [1,865](/filings/0001437749-25-016834.md) | [1,854](/filings/0001437749-25-026521.md) | [1,721](/filings/0001437749-25-034456.md) | [2,118 d](/filings/0001437749-26-010089.md) | [2,448](/filings/0001437749-26-016727.md) | [2,733](/filings/0001437749-26-027326.md) | [2,501](/filings/0001437749-25-034456.md) | [3,058 d](/filings/0001437749-26-010089.md) | [3,209](/filings/0001437749-26-016727.md) | [3,075](/filings/0001437749-26-027326.md) |
| Gross profit | $k | [5,128](/filings/0001437749-24-034931.md) | [5,766 d](/filings/0001437749-25-009211.md) | [3,804](/filings/0001437749-25-016834.md) | [2,242](/filings/0001437749-25-026521.md) | [2,488](/filings/0001437749-25-034456.md) | [3,559 d](/filings/0001437749-26-010089.md) | [1,877](/filings/0001437749-26-016727.md) | [954](/filings/0001437749-26-027326.md) | [(472)](/filings/0001437749-25-034456.md) | [675 d](/filings/0001437749-26-010089.md) | [1,842](/filings/0001437749-26-016727.md) | [2,407](/filings/0001437749-26-027326.md) |
| Research and development | $k | [1,933](/filings/0001437749-24-034931.md) | [1,381 d](/filings/0001437749-25-009211.md) | [1,321](/filings/0001437749-25-016834.md) | [1,347](/filings/0001437749-25-026521.md) | [1,798](/filings/0001437749-25-034456.md) | [1,380 d](/filings/0001437749-26-010089.md) | [1,268](/filings/0001437749-26-016727.md) | [1,193](/filings/0001437749-26-027326.md) | [1,398](/filings/0001437749-25-034456.md) | [1,436 d](/filings/0001437749-26-010089.md) | [1,512](/filings/0001437749-26-016727.md) | [1,556](/filings/0001437749-26-027326.md) |
| Selling, general and administrative | $k | [1,915](/filings/0001437749-24-034931.md) | [2,269 d](/filings/0001437749-25-009211.md) | [2,351](/filings/0001437749-25-016834.md) | [2,095](/filings/0001437749-25-026521.md) | [2,292](/filings/0001437749-25-034456.md) | [2,029 d](/filings/0001437749-26-010089.md) | [2,536](/filings/0001437749-26-016727.md) | [1,962](/filings/0001437749-26-027326.md) | [2,057](/filings/0001437749-25-034456.md) | [2,728 d](/filings/0001437749-26-010089.md) | [2,437](/filings/0001437749-26-016727.md) | [2,552](/filings/0001437749-26-027326.md) |
| Operating income | $k | [1,280](/filings/0001437749-24-034931.md) | [2,116 d](/filings/0001437749-25-009211.md) | [132](/filings/0001437749-25-016834.md) | [(1,200)](/filings/0001437749-25-026521.md) | [(1,602)](/filings/0001437749-25-034456.md) | [150 d](/filings/0001437749-26-010089.md) | [(1,981)](/filings/0001437749-26-016727.md) | [(2,522)](/filings/0001437749-26-027326.md) | [(3,927)](/filings/0001437749-25-034456.md) | [(3,489) d](/filings/0001437749-26-010089.md) | [(2,118)](/filings/0001437749-26-016727.md) | [(1,717)](/filings/0001437749-26-027326.md) |
| Interest expense | $k | [48.0](/filings/0001437749-24-034931.md) | [59.0 d](/filings/0001437749-25-009211.md) | [69.0](/filings/0001437749-25-016834.md) | [39.0](/filings/0001437749-25-026521.md) | [187](/filings/0001437749-25-034456.md) | [111 d](/filings/0001437749-26-010089.md) | [97.0](/filings/0001437749-26-016727.md) | [108](/filings/0001437749-26-027326.md) | [87.0](/filings/0001437749-25-034456.md) | [78.0 d](/filings/0001437749-26-010089.md) | [54.0](/filings/0001437749-26-016727.md) | [71.0](/filings/0001437749-26-027326.md) |
| Income tax | $k | [4.0](/filings/0001437749-24-034931.md) | [(2.0) d](/filings/0001437749-25-009211.md) | [7.0](/filings/0001437749-25-016834.md) | [(6.0)](/filings/0001437749-25-026521.md) | [13.0](/filings/0001437749-25-034456.md) | [(11.0) d](/filings/0001437749-26-010089.md) | [5.0](/filings/0001437749-26-016727.md) | [1.0](/filings/0001437749-26-027326.md) | [(1.0)](/filings/0001437749-25-034456.md) | [13.0 d](/filings/0001437749-26-010089.md) | [(3.0)](/filings/0001437749-26-016727.md) | [3.0](/filings/0001437749-26-027326.md) |
| Net income | $k | [1,192](/filings/0001437749-24-034931.md) | [2,042 d](/filings/0001437749-25-009211.md) | [108](/filings/0001437749-25-034456.md) | [(1,550)](/filings/0001437749-25-034456.md) | [(2,094)](/filings/0001437749-25-034456.md) | [(305) d](/filings/0001437749-26-010089.md) | [(2,191)](/filings/0001437749-26-027326.md) | [(2,670)](/filings/0001437749-26-027326.md) | [(4,007)](/filings/0001437749-25-034456.md) | [(5,948) d](/filings/0001437749-26-010089.md) | [(2,206)](/filings/0001437749-26-027326.md) | [(887)](/filings/0001437749-26-027326.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001437749-24-034931.md) | not reported | [0.01](/filings/0001437749-25-016834.md) | [(0.11)](/filings/0001437749-25-026521.md) | [(0.14)](/filings/0001437749-25-034456.md) | not reported | [(0.14)](/filings/0001437749-26-016727.md) | [(0.17)](/filings/0001437749-26-027326.md) | [(0.24)](/filings/0001437749-25-034456.md) | not reported | [(0.13)](/filings/0001437749-26-016727.md) | [(0.05)](/filings/0001437749-26-027326.md) |
| Basic EPS | $ per share | [0.09](/filings/0001437749-24-034931.md) | not reported | [0.01](/filings/0001437749-25-016834.md) | [(0.11)](/filings/0001437749-25-026521.md) | [(0.14)](/filings/0001437749-25-034456.md) | not reported | [(0.14)](/filings/0001437749-26-016727.md) | [(0.17)](/filings/0001437749-26-027326.md) | [(0.24)](/filings/0001437749-25-034456.md) | not reported | [(0.13)](/filings/0001437749-26-016727.md) | [(0.05)](/filings/0001437749-26-027326.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [28.1](/filings/0001437749-23-032178.md) | [34.6](/filings/0001437749-25-009211.md) | [35.3](/filings/0001437749-24-017076.md) | [29.9](/filings/0001437749-24-026817.md) | [30.1](/filings/0001437749-24-034931.md) | [29.6](/filings/0001437749-25-034456.md) | [25.3](/filings/0001437749-25-016834.md) | [27.4](/filings/0001437749-25-026521.md) | [24.3](/filings/0001437749-25-034456.md) | [24.2](/filings/0001437749-26-027326.md) | [11.2](/filings/0001437749-26-016727.md) | [23.2](/filings/0001437749-26-027326.md) |
| Total assets | $m | [36.5](/filings/0001437749-23-032178.md) | [47.8](/filings/0001437749-25-009211.md) | [51.9](/filings/0001437749-24-017076.md) | [47.5](/filings/0001437749-24-026817.md) | [49.7](/filings/0001437749-24-034931.md) | [51.9](/filings/0001437749-25-034456.md) | [49.1](/filings/0001437749-25-016834.md) | [50.2](/filings/0001437749-25-026521.md) | [46.1](/filings/0001437749-25-034456.md) | [44.8](/filings/0001437749-26-027326.md) | [32.4](/filings/0001437749-26-016727.md) | [43.0](/filings/0001437749-26-027326.md) |
| Current liabilities | $m | [22.1](/filings/0001437749-23-032178.md) | [29.6](/filings/0001437749-25-009211.md) | [28.5](/filings/0001437749-24-017076.md) | [24.6](/filings/0001437749-24-026817.md) | [26.9](/filings/0001437749-24-034931.md) | [25.4](/filings/0001437749-25-034456.md) | [21.5](/filings/0001437749-25-016834.md) | [21.5](/filings/0001437749-25-026521.md) | [20.6](/filings/0001437749-25-034456.md) | [21.3](/filings/0001437749-26-027326.md) | [6.6](/filings/0001437749-26-016727.md) | [10.8](/filings/0001437749-26-027326.md) |
| Total liabilities | $m | [22.5](/filings/0001437749-23-032178.md) | [30.9](/filings/0001437749-25-009211.md) | [29.7](/filings/0001437749-24-017076.md) | [25.6](/filings/0001437749-24-026817.md) | [28.8](/filings/0001437749-24-034931.md) | [27.0](/filings/0001437749-25-034456.md) | [22.8](/filings/0001437749-25-016834.md) | [22.6](/filings/0001437749-25-026521.md) | [21.4](/filings/0001437749-25-034456.md) | [22.3](/filings/0001437749-26-027326.md) | [8.1](/filings/0001437749-26-016727.md) | [11.7](/filings/0001437749-26-027326.md) |
| Long-term debt | $m | not reported | [1.4](/filings/0001437749-24-009469.md) | [1.4](/filings/0001437749-24-017076.md) | [1.2](/filings/0001437749-24-026817.md) | [3.4](/filings/0001437749-24-034931.md) | [3.1](/filings/0001437749-25-009211.md) | [2.8](/filings/0001437749-25-016834.md) | [2.3](/filings/0001437749-25-026521.md) | [1.9](/filings/0001437749-25-034456.md) | [3.0](/filings/0001437749-26-010089.md) | [3.4](/filings/0001437749-26-016727.md) | [2.8](/filings/0001437749-26-027326.md) |
| Shareholders' equity | $m | [14.0](/filings/0001437749-24-034931.md) | [16.9](/filings/0001437749-26-010089.md) | [22.2](/filings/0001437749-25-034456.md) | [21.8](/filings/0001437749-25-034456.md) | [20.9](/filings/0001437749-25-034456.md) | [24.9](/filings/0001437749-26-027326.md) | [26.3](/filings/0001437749-26-027326.md) | [27.7](/filings/0001437749-26-027326.md) | [24.7](/filings/0001437749-25-034456.md) | [22.5](/filings/0001437749-26-027326.md) | [24.3](/filings/0001437749-26-027326.md) | [31.2](/filings/0001437749-26-027326.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [130 d](/filings/0001437749-24-034931.md) | [5,038 d](/filings/0001437749-25-009211.md) | [147](/filings/0001437749-25-016834.md) | [(220) d](/filings/0001437749-25-026521.md) | [(16.0) d](/filings/0001437749-25-034456.md) | [116 d](/filings/0001437749-26-010089.md) | [(2,126)](/filings/0001437749-26-016727.md) | [628 d](/filings/0001437749-26-027326.md) | [131 d](/filings/0001437749-25-034456.md) | [(1,895) d](/filings/0001437749-26-010089.md) | [721](/filings/0001437749-26-016727.md) | [1,469 d](/filings/0001437749-26-027326.md) |
| Capital expenditure | $k | [1,643 d](/filings/0001437749-24-034931.md) | [3,737 d](/filings/0001437749-25-009211.md) | [85.0](/filings/0001437749-25-016834.md) | [3,968 d](/filings/0001437749-25-026521.md) | [67.0 d](/filings/0001437749-25-034456.md) | [1,284 d](/filings/0001437749-26-010089.md) | [1,349](/filings/0001437749-26-016727.md) | [1,354 d](/filings/0001437749-26-027326.md) | [1,385 d](/filings/0001437749-25-034456.md) | [(924) d](/filings/0001437749-26-010089.md) | [658](/filings/0001437749-26-016727.md) | [470 d](/filings/0001437749-26-027326.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-02) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.7](/filings/0001437749-23-032178.md) | [13.2](/filings/0001437749-24-017076.md) | [13.7](/filings/0001437749-24-026817.md) | [14.1](/filings/0001437749-24-034931.md) | [14.5](/filings/0001437749-25-016834.md) | [14.4](/filings/0001437749-25-026521.md) | [14.6](/filings/0001437749-25-034456.md) | [15.3](/filings/0001437749-26-016727.md) | [15.9](/filings/0001437749-26-027326.md) | [16.5](/filings/0001437749-25-034456.md) | [17.5](/filings/0001437749-26-016727.md) | [18.1](/filings/0001437749-26-027326.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,317,741 at 2026-08-07, from the cover of the [10-Q filed 2026-08-12](/filings/0001437749-26-027326.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.